NPI: 1467448498 · AIKEN, SC 29801 · Psychiatric Hospital Unit · NPI assigned 09/26/2005
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR VP) |
| NPI Enumeration Date | 09/26/2005 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 149,880 | $4.90M |
| 2019 | 165,560 | $4.57M |
| 2020 | 121,443 | $3.47M |
| 2021 | 130,134 | $4.63M |
| 2022 | 142,143 | $4.85M |
| 2023 | 153,516 | $5.32M |
| 2024 | 136,257 | $3.77M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 65,348 | 50,568 | $9.17M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 38,637 | 32,228 | $3.14M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 40,403 | 36,729 | $1.79M |
| 59025 | Fetal non-stress test | 18,216 | 7,309 | $1.42M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3,291 | 1,478 | $1.22M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8,421 | 7,859 | $952K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9,589 | 8,660 | $872K |
| 87070 | 6,429 | 5,937 | $811K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 11,425 | 3,818 | $670K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6,247 | 5,551 | $629K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 12,364 | 10,028 | $484K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6,479 | 6,243 | $449K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,594 | 3,005 | $433K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2,764 | 2,613 | $420K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3,654 | 3,387 | $402K |
| 80053 | Comprehensive metabolic panel | 42,245 | 35,808 | $319K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,068 | 1,907 | $304K |
| 81001 | 30,983 | 27,165 | $301K | |
| 71045 | Radiologic examination, chest; single view | 19,754 | 17,583 | $278K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3,208 | 3,104 | $257K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 29,319 | 26,536 | $250K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 15,313 | 13,637 | $232K |
| 70450 | Computed tomography, head or brain; without contrast material | 6,824 | 6,203 | $215K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,639 | 3,383 | $212K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 7,580 | 2,425 | $207K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 6,753 | 2,443 | $206K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,162 | 2,051 | $198K |
| 81003 | 12,927 | 11,727 | $195K | |
| 81025 | 20,925 | 18,673 | $192K | |
| 82962 | 7,338 | 3,906 | $186K | |
| 73610 | 2,270 | 2,111 | $184K | |
| 73130 | 1,962 | 1,849 | $180K | |
| 73630 | 3,122 | 2,952 | $177K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5,750 | 5,397 | $175K |
| 71046 | Radiologic examination, chest; 2 views | 6,703 | 6,248 | $168K |
| 73564 | 2,867 | 2,688 | $155K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,696 | 1,659 | $145K |
| 82565 | 765 | 716 | $143K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,302 | 3,092 | $139K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 15,039 | 13,313 | $135K |
| 80048 | Basic metabolic panel (calcium, ionized) | 15,514 | 13,187 | $132K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 305 | 270 | $119K |
| 76819 | Fetal biophysical profile; without non-stress testing | 796 | 566 | $109K |
| 93971 | 1,300 | 1,203 | $104K | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21,635 | 19,238 | $103K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1,845 | 1,801 | $100K |
| 97597 | 1,734 | 885 | $100K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,013 | 926 | $97K |
| 80061 | Lipid panel | 2,799 | 2,641 | $95K |
| 87077 | 5,718 | 4,847 | $94K | |
| 84112 | 678 | 582 | $93K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,576 | 1,399 | $92K |
| 73110 | 1,250 | 1,183 | $90K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,076 | 2,878 | $90K |
| 73030 | 1,917 | 1,763 | $90K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,703 | 2,505 | $87K |
| 72100 | 2,479 | 2,331 | $86K | |
| 83655 | 1,822 | 1,759 | $82K | |
| 10060 | 248 | 229 | $75K | |
| 87420 | 737 | 702 | $70K | |
| 76775 | 1,160 | 1,110 | $61K | |
| J2704 | Injection, propofol, 10 mg | 7,898 | 6,686 | $51K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,804 | 2,436 | $47K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 24,991 | 20,921 | $47K |
| 93970 | 317 | 304 | $46K | |
| 74018 | 1,416 | 1,224 | $46K | |
| 80306 | 2,348 | 2,001 | $43K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,556 | 3,126 | $43K |
| 82948 | 3,652 | 1,924 | $42K | |
| 76642 | 983 | 929 | $41K | |
| 94010 | 131 | 128 | $41K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,093 | 2,779 | $41K |
| 87210 | 1,194 | 1,122 | $40K | |
| 72040 | 601 | 556 | $38K | |
| 76830 | Ultrasound, transvaginal | 455 | 438 | $36K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,499 | 2,449 | $35K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,406 | 4,633 | $35K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 860 | 737 | $34K |
| 73502 | 1,088 | 1,020 | $34K | |
| 0353U | 740 | 695 | $33K | |
| 12001 | 165 | 156 | $30K | |
| 87430 | 4,572 | 4,350 | $29K | |
| 73080 | 455 | 430 | $27K | |
| 82247 | 1,154 | 769 | $27K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 732 | 711 | $27K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 15,477 | 13,019 | $27K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,585 | 2,254 | $26K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 52,404 | 43,162 | $25K |
| 77066 | Tomosynthesis, mammo | 276 | 270 | $25K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,803 | 1,686 | $24K |
| 85027 | 9,364 | 8,245 | $24K | |
| 88312 | 1,152 | 755 | $22K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 86 | 84 | $21K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,072 | 1,859 | $18K |
| 76801 | 1,928 | 1,694 | $18K | |
| 93976 | 770 | 737 | $17K | |
| 73590 | 383 | 356 | $16K | |
| 99381 | 241 | 220 | $15K | |
| 76536 | 171 | 167 | $13K | |
| G0378 | Hospital observation service, per hour | 3,696 | 2,303 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 433 | 424 | $12K |
| 73090 | 218 | 199 | $12K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 8,062 | 6,897 | $12K |
| 82731 | 154 | 141 | $12K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 15 | 14 | $12K |
| 84439 | 1,702 | 1,572 | $10K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 27 | 27 | $9K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 27 | 27 | $8K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 701 | 673 | $8K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 403 | 345 | $8K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 5,474 | 4,703 | $8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 990 | 876 | $8K |
| 81002 | 177 | 171 | $8K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 51 | 48 | $7K |
| 71250 | 72 | 67 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,183 | 1,100 | $7K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 908 | 529 | $7K |
| 96376 | 1,743 | 1,339 | $7K | |
| 97162 | 154 | 132 | $7K | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 63 | 62 | $6K |
| 97161 | 102 | 92 | $6K | |
| 88304 | 631 | 578 | $5K | |
| 86850 | 4,288 | 3,762 | $5K | |
| 95816 | 26 | 25 | $4K | |
| 82810 | 174 | 146 | $4K | |
| 97116 | 1,588 | 834 | $4K | |
| 86140 | 347 | 307 | $4K | |
| 93975 | 111 | 108 | $3K | |
| 74178 | 13 | 12 | $3K | |
| 87040 | 4,555 | 2,416 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,043 | 1,848 | $3K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 104 | 95 | $3K |
| 12011 | 12 | 12 | $3K | |
| 72072 | 85 | 81 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 411 | 369 | $3K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 726 | 660 | $3K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 227 | 153 | $3K |
| 70486 | 98 | 91 | $3K | |
| G0008 | Administration of influenza virus vaccine | 394 | 361 | $3K |
| 84484 | 18,444 | 13,678 | $3K | |
| 83880 | 7,108 | 6,278 | $2K | |
| A9270 | Non-covered item or service | 28,828 | 6,883 | $2K |
| 85018 | 275 | 223 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,167 | 1,910 | $2K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,156 | 914 | $2K |
| 82803 | 1,698 | 1,365 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 4,785 | 4,199 | $2K |
| 90791 | Psychiatric diagnostic evaluation | 3,285 | 2,561 | $2K |
| 74240 | 13 | 13 | $2K | |
| 84702 | 4,974 | 4,013 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 6,122 | 4,746 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 10,805 | 9,408 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,232 | 1,116 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 6,319 | 5,657 | $1K |
| 82375 | 133 | 115 | $1K | |
| 83690 | 19,781 | 17,630 | $1K | |
| 93017 | 29 | 29 | $1K | |
| 73140 | 16 | 14 | $1K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 959 | 855 | $1K |
| 83735 | 9,680 | 8,122 | $1K | |
| 83540 | 38 | 37 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,486 | 2,143 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9,352 | 8,679 | $1K |
| 86592 | 410 | 384 | $1K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 1,825 | 1,598 | $1K |
| 82570 | 452 | 369 | $975.98 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 5,498 | 4,688 | $924.97 |
| 84443 | Thyroid stimulating hormone (TSH) | 3,994 | 3,686 | $909.41 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 232 | 217 | $907.64 |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,616 | 1,335 | $901.97 |
| 80076 | 2,603 | 2,378 | $893.59 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 855 | 719 | $836.54 |
| 74022 | 45 | 39 | $791.76 | |
| 85379 | 3,011 | 2,813 | $709.99 | |
| 72170 | 51 | 44 | $689.05 | |
| 97165 | 24 | 24 | $686.81 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 108 | 90 | $650.91 |
| C9113 | Injection, pantoprazole sodium, per vial | 308 | 224 | $629.39 |
| 87186 | 5,734 | 4,845 | $599.65 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1,847 | 1,643 | $599.61 |
| 86900 | 6,255 | 5,486 | $582.38 | |
| 81005 | 480 | 439 | $579.61 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 25 | 25 | $547.76 |
| 83615 | 450 | 368 | $523.94 | |
| 70491 | 13 | 12 | $502.74 | |
| 77065 | Tomosynthesis, mammo | 15 | 13 | $473.16 |
| 82272 | 57 | 51 | $467.55 | |
| 82330 | 37 | 32 | $434.63 | |
| 73060 | 14 | 14 | $414.07 | |
| 85610 | 6,611 | 5,698 | $402.56 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,154 | 2,329 | $401.96 |
| C1769 | Guide wire | 334 | 275 | $389.99 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,684 | 2,491 | $376.61 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 320 | 276 | $372.49 |
| 85730 | 5,994 | 5,205 | $371.34 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 373 | 328 | $350.62 |
| J8540 | Dexamethasone, oral, 0.25 mg | 28 | 28 | $332.22 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 33 | 25 | $329.11 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 200 | 116 | $279.17 |
| 90670 | 15 | 14 | $266.55 | |
| 87806 | 1,084 | 1,001 | $264.26 | |
| Q3014 | Telehealth originating site facility fee | 14 | 14 | $258.88 |
| 83986 | 13 | 12 | $224.69 | |
| 83605 | 4,087 | 3,381 | $204.60 | |
| 84100 | 508 | 406 | $202.43 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,913 | 1,629 | $190.24 |
| 84156 | 633 | 447 | $183.76 | |
| 86901 | 6,256 | 5,488 | $149.08 | |
| 90686 | 30 | 27 | $131.39 | |
| 87899 | 1,790 | 1,644 | $117.58 | |
| 82550 | 1,456 | 1,301 | $117.39 | |
| 90461 | 1,228 | 1,124 | $106.99 | |
| 90715 | 1,199 | 1,134 | $101.60 | |
| 82010 | 442 | 385 | $71.40 | |
| J0694 | Injection, cefoxitin sodium, 1 gm | 1,584 | 1,261 | $69.36 |
| 88342 | 14 | 12 | $49.30 | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,038 | 634 | $33.24 |
| G0009 | Administration of pneumococcal vaccine | 317 | 304 | $31.02 |
| 90633 | 62 | 48 | $29.55 | |
| 88302 | 12 | 12 | $14.17 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,213 | 1,095 | $10.68 |
| 83050 | 130 | 114 | $6.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 4,477 | 3,708 | $4.60 |
| J2060 | Injection, lorazepam, 2 mg | 1,163 | 971 | $3.09 |
| A9585 | Injection, gadobutrol, 0.1 ml | 112 | 106 | $1.09 |
| J1940 | Injection, furosemide, up to 20 mg | 181 | 140 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 164 | 143 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 90 | 77 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 630 | 516 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 77 | 69 | $0.00 |
| 36430 | 31 | 24 | $0.00 | |
| 70498 | 12 | 12 | $0.00 | |
| 86920 | 19 | 12 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 86 | 40 | $0.00 |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 27 | 24 | $0.00 |
| 85651 | 140 | 114 | $0.00 | |
| 87205 | 152 | 117 | $0.00 | |
| 90651 | 20 | 19 | $0.00 | |
| 87640 | 67 | 53 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 147 | 121 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 15 | 13 | $0.00 |
| 80069 | 13 | 12 | $0.00 | |
| 87340 | 24 | 24 | $0.00 | |
| 88307 | 12 | 12 | $0.00 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 24 | 24 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 28 | 28 | $0.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 17 | 13 | $0.00 |
| 84132 | 34 | 32 | $0.00 | |
| 85652 | 17 | 16 | $0.00 | |
| 82248 | 1,038 | 704 | $0.00 | |
| 80164 | 13 | 12 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 424 | 386 | $0.00 |
| 87075 | 53 | 42 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 1,061 | 912 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 241 | 233 | $0.00 |
| 84550 | 640 | 550 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 49 | 45 | $0.00 |
| J2800 | Injection, methocarbamol, up to 10 ml | 29 | 24 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 600 | 480 | $0.00 |
| 85384 | 100 | 91 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 145 | 88 | $0.00 |
| 85014 | 58 | 48 | $0.00 | |
| 87641 | 166 | 139 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 173 | 150 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 56 | 48 | $0.00 |
| 84295 | 19 | 18 | $0.00 | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 15 | 12 | $0.00 |
| 96367 | 16 | 12 | $0.00 | |
| 94727 | 28 | 28 | $0.00 | |
| 93925 | 14 | 14 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 30 | 25 | $0.00 |
| 82947 | 23 | 20 | $0.00 | |
| 84520 | 19 | 18 | $0.00 | |
| 99152 | 27 | 26 | $0.00 | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 14 | 13 | $0.00 |